⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ONCY News
Oncolytics Biotech, Inc. Common Shares
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers
globenewswire.com
ONCY
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer
globenewswire.com
ONCY
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment
globenewswire.com
ONCY
Cancer Drug Spending Is Headed Past $400 Billion as Colorectal and Pancreatic Cancers Move Up the Research Agenda
prnewswire.com
EXEL
LLY
RVMD
ONCY
GMAB
Form 8-K
sec.gov
ONCY
Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
globenewswire.com
ONCY
Form 8-K
sec.gov
ONCY